As many remember, both in their minds and pockets, Brent crude prices reached a decade-high last year, impacting oil prices globally. In 2023, global crude prices thankfully moderated in the first half. But with both Saudi Arabia and Russia extending their oil production cuts until the end of the year and U.S. oil reserve figures
Metaverse stocks emerged with a bang a couple of years ago. In fact, Mark Zuckerberg even changed the name of his social media company to Meta Platforms (NASDAQ:META), cementing the idea that the metaverse would be the destination of the future. And yet, there’s little sign of much follow-through on the concept today. So far,
In this article C RDW CTVA MRNA SAVE 9868-HK AAL 9866-HK ADBE F GM Follow your favorite stocksCREATE FREE ACCOUNT David Wadhwani, senior vice president of digital media for Adobe Systems, speaks during the launch of Adobe Creative Cloud and CS6 in San Francisco on April 23, 2012. David Paul Morris | Bloomberg | Getty
The cannabis market is in disarray. In Canada, where the recreational drug was legalized nationwide in 2018, the market has all but collapsed. High government taxes have pushed cannabis users to a thriving black market while too many companies have oversupplied the legal industry. The result for cannabis companies has been poor sales and plunging
Healthcare is a sector that has underperformed the broader stock market this year. The S&P 500 Health Care Sector Index is down over 2.50% year-to-date versus a 17% gain in the benchmark S&P 500 index. The decline has been broad-based as investors focus their capital allocations on high-flying technology stocks at the expense of pharmaceutical
Investors need to be aware of the volatility of their stocks. Owning too many high-volatility positions can create a scenario in which your portfolio loses more than the S&P 500 index during bear markets. The higher the beta, the more volatile the stock is expected to be relative to the S&P 500 index. Low-beta stocks
U.S. equities markets have had a decent albeit volatile year thus far, as inflation, interest rates, and geopolitical tensions have, at one time or another, weighed on investor sentiment. Let’s have a look at the numbers. Towards the end of July, the S&P 500 index had reached peak annual performance, at one point returning 19.5%.
A member of the Mississippi National Guard receives a dose of the Moderna COVID-19 vaccine in his arm, in Flowood, Mississippi. Rogelio V. Solis | AP Check out the companies making headlines before the bell. Moderna — Moderna shares rose more than 3% in early trading after the Centers for Disease Control and Prevention recommended updated Covid vaccine
When it comes to communications stocks, knowing which ones to avoid is at least as important as knowing which ones to buy. I would definitely avoid any of the streaming stocks in general, and I’d stay far away from the companies that own both cable channels and streaming channels. That’s because the competition is intense
It makes sense to invest in autonomous driving stocks moving forward. Whether in September or any other month, the research is clear: The market is primed for growth boasting an annual growth rate approaching 23% between this year and 2028. The next five years are bound to produce spectacular gains for investors overall. That’s the
The pharmaceutical industry is one of the most dynamic and innovative sectors in the world. It is constantly developing new drugs and treatments to address various health challenges and improve the quality of life of millions of people. However, not every pharma company is successful in producing positive clinical trial results. If you just took
In the dynamic world of stock trading, there’s no denying the importance of knowing which stocks billionaires are selling. Following these financial titans in their investment decisions can be invaluable in navigating the stock market’s volatility. Their access to top-tier research and wealth of experience often shape market trends, unlocking doors to potential investment avenues
QuantumScape (NYSE:QS) is a speculative growth stock, but this categorization isn’t what makes QS stock a questionable investment opportunity. You know the saying: nothing ventured, nothing gained. If the odds are in your favor, taking calculated risks in early-stage stocks with a high degree of uncertainty can be a profitable strategy. The issue with this
Previously, we gave EVgo (NASDAQ:EVGO) stock a “D” grade along with a warning for prospective shareholders. Now, even as we uncover more information and developments, we still can’t enthusiastically recommend investing in EVgo. Maybe you’re intrigued with EVgo because you envision vigorous growth in the electric vehicle (EV) charging market. Your optimism is understandable, but EVgo
Lucid Group (NASDAQ:LCID) stock is one I’ve had mixed opinions of in the past. On the one hand, this is a company with some clear speculative upside, particularly as a vehicle for investors to bet on the overall electric vehicle space. However, it’s also clear that Lucid Group is one that has been plagued by
Even with a relatively small sum, say $500, there are plenty of stocks to buy that can pave the way for a brighter financial future. Contrary to what many believe, you don’t need a fortune to start investing, which is why we’ve compiled this list of stocks to buy with less than $500. While market
Almost two years ago, I wrote about seven stocks to buy whose products and services were in high demand. What made the story unique is that each company recommended had the word “Brands” as part of their corporate name. At the time, Finviz.com said 34 stocks listed in the United States were meeting this specific
Some of the best opportunities can be found in undervalued dividend stocks with growth potential. In fact, I found seven of them which have at least 2% dividend yields with relatively low valuations, and solid growth prospects ahead of them. Some of the top ones include: Undervalued Dividend Stocks with Growth Potential: IBM (IBM) Source:
It’s been a difficult time for biotechnology stocks. After a boom during the Covid-19 pandemic, the entire sector appears to have been abandoned by investors. The Standards and Practices (S&P) 500 Biotechnology Select Industry Index has declined 11% throughout the past 12 months and is down 18% throughout the last five years. Companies large and
Towards the end of 2021, Nvidia (NASDAQ:NVDA) stock was trading at $300. NVDA stock corrected to lows of $108 by October 2022 before skyrocketing by more than 200% for year-to-date. The point I want to make is that the rally in blue-chip stock can be stellar from oversold levels. It does not take time for